Paxlovid by Pfizer
Posted inTherapeutics

Paxlovid by Pfizer

PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets, co-packaged for oral use) is an anti-viral, patented drug by Pfizer. TGA: PAXLOVID: nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack. ClinicalTrials.gov: Evaluation of Protease Inhibition for COVID-19 in…
10 May 2022Posted inTherapeutics
Focus on the early treatment phase of COVID-19 disease
Posted inEarly Treatment

COVID-19 Early Treatment Protocols

Independent doctors who work on the front line, face to face with sick patients, have searched the books and their knowledge for solutions to help treat their patients with COVID-19 symptoms. Repurposing known, cheap, off-patent drugs, singularly or in combinations,…
24 May 2021Posted inEarly Treatment